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Abstract
The variety of Borrelia burgdorferi sensu lato (B. burgdorferi) genospecies leads to distinction in clinical manifestations of Lyme borreliosis
(LB). There are reports of LB clinical characteristics in China, where the B. burgdorferi genospecies in ticks and animal hosts are different
from those in Europe and North America. During May to September in 2010 and 2011, all patients who had erythema migrans (EM, more
than 5 cm in diameter) after a recent tick-bite, and sought medical care at Mudanjiang Forestry Central Hospital, Heilongjiang Province of
northeastern China, were enrolled in the study. Speciﬁc PCR was used to determine the B. burgdorferi genospecies in the disseminated
patients. Of 265 EM patients, B. burgdorferi DNA was detected in blood specimens from 15 of 55 disseminated patients. Sequence analyses
of 5S–23S rRNA, ﬂagellin, ospC, 16S rRNA and ospA genes revealed that 11 patients were infected with Borrelia garinii, three with
Borrelia afzelii and one with Borrelia valaisiana-related genospecies. Among 15 patients, 40%, 13.3% and 13.3% manifested pruritus, pain and
ulceration, respectively. Systemic symptoms, arthralgia or a swollen joint and lymphadenopathy were observed in 26.7%, 13.3% and 6.7%
patients, respectively. In northeastern China, three genospecies of LB patients were detected. The B. burgdorferi genospecies identiﬁed in
this study was predominantly B. garinii. A case infected with B. valaisiana-related genospecies was reported for the ﬁrst time.
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Introduction
Lyme borreliosis (LB) is a tick-borne disease, caused by the
complex Borrelia burgdorferi sensu lato (B. burgdorferi), including
B. burgdorferi sensu stricto, Borrelia afzelii, Borrelia garinii, Borrelia
valaisiana, Borrelia spielmanii, Borrelia lusitaniae, Borrelia bavarien-
sis, Borrelia kurtenbachii and Borrelia bissettii [1]. The disease
develops in stages, with different manifestations involving mainly
the skin, the nervous system and the joints. Early localized LB
manifests as the simple skin lesion known as erythema migrans
(EM), which is an expanding erythematous patch (usually more
than 5 cm in diameter). After haematogenous spread of
spirochetes, early localized infection may be followed by
disseminated manifestations, which consist of multiple EM in
addition to possible cardiac and neurological disorders, affecting
both central and peripheral nervous systems. Late LB usually
gives rise to arthritis in large joints, or the skin disorder known
as acrodermatatitis chronica atrophicans, commonly seen in
American and European patients [2,3].
In China, several B. burgdorferi genospecies, including B. gar-
inii, B. afzelii, B. sinica and B. valaisiana-related strains, have been
detected in ticks and rodents from about 20 provinces, and
B. garinii is the predominant genospecies [4,5]. The ﬁrst LB case
was reported in 1986 in Heilongjiang Province of northeastern
China [6]. However, the clinical characteristics and
B. burgdorferi genospecies causing LB remain unclear in China.
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE BACTERIOLOGY
Mudanjiang Forestry Central Hospital is one of the largest
specialized hospitals for tick-borne diseases in northeastern
China. Every year at the peak season of tick activity (c. from
May to September), about 1000 patients with tick-bites seek
medical care in this hospital. This study was carried out in
order to ﬁgure out the clinical characteristics and B. burgdorferi
genospecies causing LB in northeastern China.
Methods
Patients and sample collection
From May to September in 2010 and 2011, we carried out a
surveillance study on LB at Mudanjiang Forestry Central
Hospital. The patients with EM after recent tick-bites were
enrolled in the study. EM was deﬁned as single or multiple
expanding rasheswith diameter equal to ormore than 5 cmwith
or without central clearing, and did not disappear in 48 h after
tick detachment [7]. Patients were classiﬁed as having localized
or disseminated disease by the criteria used by Massarotti et al.
[8]. Localized infection was deﬁned as EM accompanied by no
more than regional lymphadenopathy, fatigue or minor head-
ache, and dissemination was deﬁned by the presence of multiple
skin lesions, abdominal pain or tenderness, generalized lymph-
adenopathy, carditis (atrioventricular heart block or pericarditis
indicated by the electrocardiogram), arthritis or arthralgias, or
symptoms of nervous system disease (lymphocytic meningitis,
cranial neuritis, particularly peripheral facial palsy and VI cranial
nerve damage, radiculoneuropathy or encephalomyelitis, and
cerebrospinal ﬂuid examination indicating lymphocytic pleocy-
tosis, except for patients with cranial neuropathy).
For each disseminated patient, EDTA-anticoagulated blood
samples were collected to detect B. burgdorferi by PCR. For
localized patients, we did not detect the pathogens in the
blood, because spirochetes mostly spread in the local cutane-
ous lesions. A standardized questionnaire was administered to
each participant to collect data on demographic information,
medical history and environmental exposure. Additional data,
including clinical manifestations, underlying medical conditions,
laboratory test results, treatment regimens and outcomes,
were reviewed from medical records. Written or oral consent
was obtained from all the patients, and the study protocol was
reviewed and approved by the institutional review boards of
the hospital.
DNA Extraction, polymerase chain reaction and DNA
sequencing
DNA was extracted from blood specimens with the QIAmp
DNA Blood Mini Kit (Qiagen, Germantown, MD, USA)
according to manufacturer’s instructions.
Nested-PCR speciﬁc for the 5S–23S rRNA intergenic
spacer gene was used for detection of B. burgdorferi DNA as
previously described [9]. The positive samples were then
subjected to ampliﬁcation of the ﬂagellin gene, outer surface
protein C (ospC) gene, 16S rRNA gene and ospA gene (Table S1
in the Supplementary Appendix). To avoid cross-contamina-
tion and sample carryover, pre- and post- PCR processing and
PCR ampliﬁcation were performed in separate rooms, and
plugged pipet tips were used for all ﬂuid transfers. After
electrophoresis, the positive amplicons were puriﬁed with the
E.Z.N.A Gel Extraction Kit (Omega Bio-Tek, Norcross, GA,
USA), and then directly sequenced on an automated DNA
sequencer (3730 DNA Sequencer, Applied Biosystems,
Carlsbad, CA, USA). The sequences obtained were compared
with previously published sequences deposited in GenBank by
using BLAST (http://blast.ncbi.nim.nih.gov/Blast.cgi).
Phylogenetic analysis
Phylogenetic analysis based on the 5S–23S rRNA intergenic
spacer gene, ﬂagellin gene, ospC gene, 16S rRNA gene and ospA
gene was conducted using MEGA Version 5.1 software [10].
The phylogenetic tree was constructed using the maximum
likelihood method. The stability of the tree was evaluated by
bootstrap analysis with 1000 replications.
Nucleotide sequence accession numbers
The nucleotide sequences determined in this study have been
submitted to Genbank with accession numbers JX888444-
JX888457 and KC189045.
Results
Identiﬁcation of B. burgdorferi from blood specimens of
disseminated patients
Of 265 EM patients, 55 had developed disseminated manifes-
tations. Among 55 disseminated patients, 15 (27.3%) patients
had positive blood tests for B. burgdorferi 5S–23S rRNA gene.
The sequencing analysis revealed that 11 were B. garinii, three
were B. afzelii and one was B. valaisiana-related. The nucleo-
tide sequences of the 5S–23S rRNA gene (GenBank accession
number: JX888453-JX888455) showed 88–100% similarities
among the 11 B. garinii strains. Compared with strain NT29
from the Japanese tick (L30130) and strain 20047 from the
European tick (L30119), B. garinii sequences in this study
showed 87–99% and 89–98% similarities, respectively. Most of
the B. garinii sequences were identical to the sequence from
rodents in China (100%, EU160461) (Fig. 1a). Borrelia afzelii
sequences from the three patients were identical, and showed
100% identity with strain VS461 from ticks in Europe (L30135)
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and strain VH6 from ticks in China (DQ150534) (Fig. 1a). The
Borrelia valaisiana-related group sequence from the patient had
100% identity with strain QLZSP1 from ticks in China
(EU247839) and showed 93% identity with the type B. valai-
siana strain Am501 from ticks in Japan (D84402) (Fig. 1a).
Sequence analyses of ﬂagellin, ospC, 16S rRNA and ospA genes
conﬁrmed the three genospecies (B. garinii, B. afzelii and
B. valaisiana-related) in our patients. They were genetically
close to those identiﬁed from ticks or rodents in China
(Fig. 1b–e), and the ospA sequence of B. garinii was genetically
identical to the ones isolated from patients in far eastern
Russia (Fig. 1e).
The epidemiological and clinical features of PCR-conﬁrmed
EM patients
The epidemiological and clinical characteristics of 15 patients
with typical PCR-conﬁrmed EM (Fig. 2) are summarized in
Table 1. The median age of the 15 patients was 49 years
(a) (b)
(c)
FIG. 1. Phylogenetic trees obtained by the maximum likelihood method. (a) (253-bp) 5S–23S rRNA intergenic spacer gene; (b) (588-bp) ﬂagellin
gene; (c) (636-bp) outer surface protein C (ospC) gene; (d) (903-bp) 16S rRNA gene; (e) (307-bp) ospA gene. Numbers on the branches indicate
percentage of replicates that reproduces the topology for each clade. Parentheses enclose GenBank numbers of the sequences used in the
phylogenetic analysis, and brackets enclose the quantity of the same sequences as this strain. Boldface indicates sequences obtained from this study.
The trees are drawn to scale, with branch lengths in the same units as those of the evolutionary distances (see scale bars) used to infer the
phylogenetic tree. Positions containing gaps, missing data and primer sequences were eliminated from the dataset.
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(range, 4–61 years) and 60% were male. The median interval
from localized EM to disseminated signs was 3 (range, 1–18)
days. The median interval from tick-bite to seeing a doctor at
the hospital was 6 days (range, 2–20 days). The median size of
lesions at presentation was 10 cm (range, 5–30 cm). The sites
of primary lesions appeared mostly in the trunk and abdomen
(40.0%). Local symptoms at the site of EM were present in
46.7% patients, including pruritus (40.0%), pain or burning
(13.3%), and ulceration or vesicles (13.3%). Around 26.7%
patients experienced systemic symptoms such as fever,
headache and fatigue; 73.3% patients had multiple lesions
including, multiple EM (40.0%) and maculopapular rash (33.3%).
Only a small proportion of patients with rash had lymphade-
nopathy (6.7%), cardiac involvement (6.7%) and arthralgia or a
swollen joint (13.3%).
Description of the case infected with B. valaisiana-related
genospecies
The patient infected with B. valaisiana-related genospecies was
a 47-year-old woman with an EM of 10 9 10 cm (Fig. 2d). She
had been bitten by a tick on the right leg in her own courtyard.
The bite site was initially a red macule, and expanded to an
erythema 3 days later. No other abnormality was found on
physical examination. All the routine laboratory tests were
normal, with a leukocyte count of 7.4 9 109/L, a neutrophil
ratio of 66%, a lymphocyte ratio of 31%, a blood platelet count
of 165 9 109/L and a haemoglobin level of 118 g/L. Ceftriax-
one sodium (2.0 g intravenously per day) was administered to
her for 14 days. After ﬁnishing the treatment, the EM
disappeared and PCR assays for B. valaisiana-related genospe-
cies became negative.
Discussion
It is known that different B. burgdorferi genospecies result in
various clinical manifestations, most probably as a consequence
of their distinctive organotropism. Differences in geographical
distribution of genospecies may explain the distinctions in the
clinical features of LB between Europe and the United States.
Borrelia burgdorferi sensu stricto remains the only human
pathogen in the United States, while three species (B. burg-
dorferi sensu stricto, B. afzelii and B. garinii) are aetiological
agents in Europe, and B. afzelii is the predominated cause of
skin lesions [2]. In a previous study, B. afzelii and B. garinii were
detected from ticks, rodents and patients in far east Russia and
Korea, which is geographically close to Mudanjiang City
[11,12]. In this study, we found three genospecies of B. burg-
dorferi (B. garinii, B. afzelii and B. valaisiana-related).
The limitation of this study was that cultures from biopsy
samples of EM lesions should be used to further conﬁrm
B. burgdorferi infection. However, it is not practical for Chinese
patients because of culture difﬁculties and poor patient
compliance.
(d) (e)
FIG. 1. (continued)
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The most common manifestations of early localized LB
generally appear at the site of the tick-bite. The feature of EM
that distinguishes it from a hypersensitivity reaction to a
tick-bite is its expanding appearance. EM usually begins as a red
macule or papule, which expands over the course of days to
weeks, presumably as the spirochetes spread centrifugally
through the skin [2]. Also, central clearing erythematous
lesions, in part as a function of time [3,13], was not common in
our study. This may be explained by the shorter period between
the appearance of the symptoms and ﬁrst medical visit in our
study. Skin lesions in our study were accompanied by pruritus in
40.0% and by pain in 13.3% of patients, compared with 54.3%
and 35.5% European B. garinii patients, and 40.2% and 34.3%
American B. b. s. s patients, respectively [13–16]. Ulceration or
vesicles were present in 13.3% of our patients, and in 8.0% of
American patients [13–16]. In previous reports, EM caused by
B. burgdorferi sensu stricto has faster spreading, more frequently
widespread haematogenous dissemination and more central
clearing than EM caused by B. afezlii and B. garinii [2]. In addition,
EM caused by B. garinii has shorter incubation and faster
evolution than B. afezlii [17]. Systemic symptoms were expe-
rienced by 26.7% of patients, compared with 37.1% of European
B. garinii patients, 50.6% of European B. afzelii patients and
68.9% of American B. b. s. s patients [13–16]. On physical
examination, localized or generalized lymphadenopathy was
present in 6.7% of our patients, compared with 38.7% of
American patients, and 13.3%of patients developed arthralgia or
a swollen joint, compared with 27.1% of B. afzelii patients in
Europeand40.3%ofB. b. s. spatients in theUnitedStates [13–16].
Borrelia valaisiana-related spirochaetes were classiﬁed as a
new genospecies (temporarily named the B. valaisiana-related
group) according to phylogenetic analyses of 16S rRNA and
ﬂagellin gene sequences [18]. It most probably circulated
between rodent reservoirs and tick vectors in east Asia,
including Japan [18,19], Korea [20], mainland China [4,9,21] and
Taiwan [22,23]. In mainland China, B. valaisiana-related strains
were isolated in the Yangtze River valley [4]. At ﬁrst, these
Borrelia spirochaetes were temporarily considered to be
members of the B. afzelii-related group based on 16S rRNA
gene sequences [24]. Then they were suggested to belong to the
B. valaisiana species, because these strains showed higher
similarity to B. valaisiana than to B. afzelii in their 16S rRNA
gene sequences and were distinguishable from B. afzelii in the
5S–23S rRNA intergenic spacer sequence [20]. This seems
(a)
(b)
(c) (d)
FIG. 2. Erythema migrans (EM) in four patients. (a) EM near the axilla. It was a classic EM with central clearing. (b) EM at the back of the waist
(20 cm in diameter) with vesicles in the centre. Borrelia afzelii was ampliﬁed from the patient’s blood. (c) EM at the right ﬂank with eschar in the
centre. Borrelia garinii was identiﬁed from the patient. (d) EM on the right leg. Borrelia valaisiana-related EM was identiﬁed from the patient.
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different from the transmission cycle maintaining B. valaisiana in
Europe, where B. valaisiana has been only found in ticks and
various avian reservoirs but never in rodents [25–27]. Because
of the different transmission, it remains to be determined
whether this new B. burgdorferi species can cause human disease.
In the current study, we diagnosed the ﬁrst human case infected
with B. valaisiana-related genospecies by sequence analysis of
the 5S–23S rRNA, ﬂagellin, ospC, 16S rRNA and ospA genes.
Disseminated infection is strongly associated with sys-
temic symptoms and multiple skin lesions [28,29]. After
haematogenous spread, spirochetes would infect the whole
body. Different B. burgdorferi sensu stricto genotypes may
have different capacities for haematogenous dissemination
during the early stage of LB [30]. However, the correlation
between different B. burgdorferi genospecies and dissemina-
tion property is not well understood. We identiﬁed three
genospecies from our disseminated patients in this hospital,
and raised the possibility of further study of the potential
different dissemination properties among these three geno-
speices.
Diverse genospecies of Borrelia burgdorferi sensu lato cause
Lyme borreliosis in northeastern China. Care should be taken
when clinical and laboratory experience from Europe and the
United States is applied to patients in China.
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